---
figid: PMC9077970__13045_2022_1262_Fig2_HTML
figtitle: Dual role of autophagy in acute myeloid leukemia
organisms:
- Salvia miltiorrhiza
- Sophora flavescens
- Homo sapiens
- Mus musculus
- Rat sarcoma virus
- Panthera tigris
- Mesocentrotus nudus
organisms_ner:
- Panthera tigris
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC9077970
filename: 13045_2022_1262_Fig2_HTML.jpg
figlink: /pmc/articles/PMC9077970/figure/Fig2/
number: F2
caption: Oncogenic mutations linking autophagy to the tumorigenesis and anticancer
  effects in AML. The FLT-ITD3 mutation in AML cells increases ATF4 protein-mediated
  basal autophagy to promote tumorigenesis. Overexpression of the enzyme sirtuin 1
  is frequently observed in AML patients with FLT3-ITD mutation, although the role
  of sirtuin 1 in AML autophagy is unclear. A RET protein in FLT3-dependent AML inhibits
  autophagy via mTORC1 pathways, while the RET inhibitor suppresses leukemic cell
  proliferation by autophagic degradation of mutant FLT3. Also, a FLT3-ITD inhibitor
  induces expression of the lipid ceramide to execute lethal mitophagy. Inactivation
  of WWP1 induces autophagy to impair tumor growth. Inhibition of c-KITN822K blocks
  constitutive activation of c-KIT and induces both apoptosis and autophagy. The transcription
  factor TFEB induces AML differentiation and apoptosis through the IDH1/2–TET2 axis
  in Myc protein-deficient conditions. The mutant NPM1 gene activates leukemogenic
  autophagy through PML/AKT signaling, ULK1 protein stabilization, and PKM2 enzyme-mediated
  phosphorylation of the Beclin-1 protein. The KITD816V mutation in AML constitutively
  activates the STAT3 signaling pathway, enhancing basal autophagy to promote AML
  cell proliferation. The U2AF1S34F mutation increases autophagy flux through the
  Foxo3a transcription factor. AML cells with the TP53wild type gene can survive through
  ATG5/7 protein-mediated autophagy. The Hsp70 inhibitor, 17-AAG, under a condition
  of metabolic stress, induces degradation of TP53R248Q in AML through chaperone-mediated
  autophagy
papertitle: The dual role of autophagy in acute myeloid leukemia.
reftext: Wonhyoung Seo, et al. J Hematol Oncol. 2022;15:51.
year: '2022'
doi: 10.1186/s13045-022-01262-y
journal_title: Journal of Hematology & Oncology
journal_nlm_ta: J Hematol Oncol
publisher_name: BioMed Central
keywords: Acute myeloid leukemia | Autophagy | Apoptosis | Therapeutics
automl_pathway: 0.9284908
figid_alias: PMC9077970__F2
figtype: Figure
redirect_from: /figures/PMC9077970__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9077970__13045_2022_1262_Fig2_HTML.html
  '@type': Dataset
  description: Oncogenic mutations linking autophagy to the tumorigenesis and anticancer
    effects in AML. The FLT-ITD3 mutation in AML cells increases ATF4 protein-mediated
    basal autophagy to promote tumorigenesis. Overexpression of the enzyme sirtuin 1
    is frequently observed in AML patients with FLT3-ITD mutation, although the role
    of sirtuin 1 in AML autophagy is unclear. A RET protein in FLT3-dependent AML
    inhibits autophagy via mTORC1 pathways, while the RET inhibitor suppresses leukemic
    cell proliferation by autophagic degradation of mutant FLT3. Also, a FLT3-ITD
    inhibitor induces expression of the lipid ceramide to execute lethal mitophagy.
    Inactivation of WWP1 induces autophagy to impair tumor growth. Inhibition of c-KITN822K
    blocks constitutive activation of c-KIT and induces both apoptosis and autophagy.
    The transcription factor TFEB induces AML differentiation and apoptosis through
    the IDH1/2–TET2 axis in Myc protein-deficient conditions. The mutant NPM1 gene
    activates leukemogenic autophagy through PML/AKT signaling, ULK1 protein stabilization,
    and PKM2 enzyme-mediated phosphorylation of the Beclin-1 protein. The KITD816V
    mutation in AML constitutively activates the STAT3 signaling pathway, enhancing
    basal autophagy to promote AML cell proliferation. The U2AF1S34F mutation increases
    autophagy flux through the Foxo3a transcription factor. AML cells with the TP53wild
    type gene can survive through ATG5/7 protein-mediated autophagy. The Hsp70 inhibitor,
    17-AAG, under a condition of metabolic stress, induces degradation of TP53R248Q
    in AML through chaperone-mediated autophagy
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FLT3
  - SIRT1
  - STAT3
  - ATF4
  - RET
  - ULK1
  - PML
  - ATG5
  - ATG7
  - MYC
  - TFEB
  - IDH1
  - IDH2
  - WWP1
  - KIT
  - Flt3
  - Sirt1
  - Foxo3
  - Stat3
  - Atf4
  - Ret
  - Ulk1
  - Pml
  - Fxyd1
  - Akt1
  - Atg5
  - Pkm
  - Atg7
  - Myc
  - Nol3
  - Tfeb
  - Idh1
  - Idh2
  - Wwp1
  - Kit
  - FOXO3
  - MTOR
  - RPTOR
  - AKT1
  - AKT2
  - AKT3
  - PKM
  - PKLR
  - BECN1
  - pak2a
  - itpka
  - flt3
  - kita
  - ngfra
  - sirt1
  - foxo3a
  - stat3
  - atf4a
  - ret
  - ulk1b
  - atg5
  - pkma
  - atg7
  - myca
  - mycbp2
  - tfeb
  - idh1
  - idh2
  - smurf1
---
